“Oral”的搜索结果，显示 101-110 项，共有 4334 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients will be randomized in a 1:1 ratio to receive either alectinib, 600 mg orally twice daily (BID), or critozinib, 250 mg orally BID. ... oral, target dose ...

2. 口腔颌面外科- 临床试验- 妙佑医疗国际

   妙佑医疗国际明尼苏达州院区提供专门的外科专业知识，以治疗那些存在面部、口腔、牙齿、颌部和颈部疾病和畸形的患者。

3. 种植牙手术- 妙佑医疗国际

   International Journal of Oral and Maxillofacial Implants. 2016;31:535. Oral and craniomaxillofacial implant surgery 2017. American Association of Oral and ...

4. 头颈癌- 医生与科室- 妙佑医疗国际

   Kevin Arce, M.D., D.M.D.. Oral and Maxillofacial Surgeon. Rochester, MN. 擅长领域：. Cancer rehabilitation, Cancer treatment, Skin biopsy, Trauma care ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients will be randomized in a 1:1 ratio to receive either alectinib, 600 mg orally twice daily (BID), or critozinib, 250 mg orally BID. ... oral, target dose ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients will be randomized in a 1:1 ratio to receive either alectinib, 600 mg orally twice daily (BID), or critozinib, 250 mg orally BID. ... oral, target dose ...

7. 口臭 - 诊断与治疗- 妙佑医疗国际

   Swartz MH. The oral cavity and pharynx. In: Textbook of Physical Diagnosis: History and Examination. 8th ed. Elsevier; 2021. Floss/interdental cleaners ...

8. 妙佑医疗国际 - 白舌 看医生的时间

   Felix DH, et al. Oral medicine: 6. White lesions. Dental Update. 2013;40:150. Reamy BV, et al. Common tongue conditions in primary care. American Family ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients will be randomized in a 1:1 ratio to receive either alectinib, 600 mg orally twice daily (BID), or critozinib, 250 mg orally BID. ... oral, target dose ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Patients will be randomized in a 1:1 ratio to receive either alectinib, 600 mg orally twice daily (BID), or critozinib, 250 mg orally BID. ... oral, target dose ...